Tag: Dicerna Pharmaceuticals

BioTech

Biotech Top Gainers: OXiGENE (NASDAQ:OXGN), AEterna Zentaris (NASDAQ:AEZS), Marina Biotech (OTCMKTS:MRNA), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Shares of Oxigene Inc (NASDAQ:OXGN) more than doubled on very heavy volume after the microcap biotech said a mid-stage study of its drug Zybrestat, when used with Roche’s Avastin, showed increased survival in ovarian cancer patients. OXiGENE Inc (NASDAQ:OXGN) stock performance was 17.48% in last session and finished the day at $2.42. Traded volume was 6,334,713 million shares in the last session and the average … Continue reading Biotech Top Gainers: OXiGENE (NASDAQ:OXGN), AEterna Zentaris (NASDAQ:AEZS), Marina Biotech (OTCMKTS:MRNA), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Jason Knox
Finance

Top News: Genetic Technologies Limited (NASDAQ:GENE), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Sovran Self Storage Inc. (NYSE:SSS), Evercore Partners Inc. (NYSE:EVR), MagnaChip Semiconductor (NYSE:MX)

Genetic Technologies Limited (NASDAQ:GENE) is a $9.9 million organization. That pales – considerably – in comparison to $1.15 billion Genomic Health, and is downright dwarfed by $2.8 billion Myriad Genetics. That small size alone is alarming to newcomers – never even mind the fact that GENE shares have fallen 73% over the past twelve months. As they say, though, nothing lasts forever, and it looks … Continue reading Top News: Genetic Technologies Limited (NASDAQ:GENE), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Sovran Self Storage Inc. (NYSE:SSS), Evercore Partners Inc. (NYSE:EVR), MagnaChip Semiconductor (NYSE:MX)

Colin Pettis